Robert J. Hariri, MD, PhD, on the Unique Potential of Chimeric Therapy
The founder, chairman, and CEO of Celularity shared his view on the concept of “chimeric vigor” and the potential benefits arising from it in the cell therapy field.
Robert J. Hariri, MD, PhD, on Cord Blood Awareness Month 2023
The founder, chairman, and CEO of Celularity shared his view on the importance of cord blood-derived cells for the medical and clinical community.
Robert J. Hariri, MD, PhD, on the Importance of Placental-Derived Stem Cells in Cell Therapy
The founder, chairman, and CEO of Celularity discussed the advantages of cells derived from umbilical cord blood versus other sources of cells for cell therapies.